| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 03/26/2008 | CN100376575C [1,4]diazepino[6,7,1-ij]quinoline derivatives as anti psychotic and antiobesity agents |
| 03/26/2008 | CN100376573C 1,3-dihydroimidazole fused-ring compound |
| 03/26/2008 | CN100376557C Quinoline derivatives as ligands for the neuropeptide y receptor |
| 03/26/2008 | CN100376530C Vitamin D analogues |
| 03/26/2008 | CN100376269C Health protection food possessing body fat reducing function |
| 03/26/2008 | CN100376267C Pharmaceutical formulation consisting of plant extract with calcium coating |
| 03/26/2008 | CN100376266C Medicated composition with weight-reducing and hypolipidemic functions |
| 03/26/2008 | CN100376243C Application of compound of esters of piperic acid in preparing hypolipidemic or health products |
| 03/26/2008 | CN100376231C Compound grease-reducing drop pills preparation method |
| 03/25/2008 | US7348433 3-[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-quinolin-2(1H)-ones or 5--[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-pyrrolo[3,2,1-IJ]quinolin-4(4H)-ones; type E antagonists; analgesics, antipyretics, antiinflammatory agents; side effect reduction |
| 03/25/2008 | US7348431 Receptor or non-receptor; 5,6,7,8,9,10-hexahydro-6,9-(epiminomethano) benzo[ alpha ][8]annulenes; anticarcinogenic, antidiabetic, antiproliferative agents; autoimmune and Crohn's diseases, acromegaly, aging resistance; coadminister tamoxifen, raloxifene, taxol, trastuzumab, tirofiban or a COX-2 inhibitor |
| 03/25/2008 | US7348426 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents |
| 03/25/2008 | US7348412 Ouabain-specific monoclonal antibodies |
| 03/25/2008 | US7348406 Administering a polypeptide or biologically active fragment; reducing body mass; metabolic-related diseases, hyperlipidemias, atherosclerosis, diabetes, and hypertension |
| 03/25/2008 | US7348359 Retinoid X receptor modulators |
| 03/25/2008 | US7348355 Treating obesity with the Microsomal triglyceride transfer protein inhibitor (S) N-{2-[benzyl(methyl)amino]-2-oxo-1-phenylethyl}-1-methyl-5-[4'-(trifluoromethyl)[1,1'-biphenyl]-2-carboxamido]-1H-indole-2-carboxamide and another lipid lowering agent such as a statin or fibrate |
| 03/25/2008 | US7348349 Oxazole derivatives |
| 03/25/2008 | US7348336 Inhibitors of IkB kinase (I Kappa B Kinase); 1-acetyl-7-bromo- beta -carboline; antiinflammatory and anticarcinogenic agent; asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, infections, and cardiac infarct |
| 03/25/2008 | US7348328 MCH antagonists for the treatment of obesity |
| 03/25/2008 | US7348327 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
| 03/25/2008 | US7348318 α-Amino-N-(diaminophosphinyl)lactam derivatives |
| 03/25/2008 | US7348162 Nucleotide sequences coding polypeptides for use in the treatment and prevention of hematopoietic disorders, osteoporosis, osteogenesis, paget's disease, periodontal disease, hypercalcemia, cancer, cachexia, and |
| 03/25/2008 | US7348138 Diagnostic methods and kits for identifying individuals exposed to West Nile virus or other viruses including Flavivirus or Pestivirus |
| 03/25/2008 | US7348017 such as 2-[Benzyl[(4-methoxyphenyl)sulfonyl]amino]-N-(3-thioxo-3H-1,2,4-dithiazol-5-yl)acetoamide; cosmetics; antiaging agents |
| 03/25/2008 | US7348000 Therapeutic compositions and methods of treating glycolipid storage related disorders |
| 03/25/2008 | US7347995 comprising an agent that targets an interleukin-15 receptor and a second agent that inhibits a costimulatory signal transmitted between a T cell and an antigen-presenting cell; treating autoimmune diseases, AIDS, vascular injuries or organ, tissue or cell transplant recipients |
| 03/25/2008 | CA2419077C A method of treating a systemic disease |
| 03/25/2008 | CA2359987C 2-amino-benzoxazinone derivatives for the treatment of obesity |
| 03/25/2008 | CA2264822C Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses |
| 03/25/2008 | CA2174707C Chromone derivatives as nk1 and substance p antagonists |
| 03/21/2008 | CA2560409A1 Herbal product comprising cinnamon and bitter melon |
| 03/20/2008 | WO2008033932A2 Biarylthiazole carboxylic acid derivatives as protein tyrosine phosphatase-ib inhibitors |
| 03/20/2008 | WO2008033931A1 Para-xylylene carboxylic acids and isothiazolones useful as protein tyrosine phosphatases (ptps) in particular ptp-ib |
| 03/20/2008 | WO2008033468A2 Azetidine and azetidone derivatives useful in treating pain and disorders of lipid metabolism |
| 03/20/2008 | WO2008033465A1 Azetidinone derivatives and methods of use thereof |
| 03/20/2008 | WO2008033460A2 Treating pain, diabetes, and lipid metabolism disorders |
| 03/20/2008 | WO2008033456A1 Spiro-condensed azetidine derivatives useful in treating pain, diabetes and disorders of lipid metabilism |
| 03/20/2008 | WO2008033431A1 Spirocyclic azetidinone derivatives for the treatment of disorders of lipid metabolism, pain, diabetes and other disorders |
| 03/20/2008 | WO2008032764A1 Fused heterocyclic derivative |
| 03/20/2008 | WO2008032678A1 Adhesive preparation |
| 03/20/2008 | WO2008032665A1 Novel phenylacetic acid derivative |
| 03/20/2008 | WO2008032506A1 Mineral water and process for producing the mineral water |
| 03/20/2008 | WO2008032450A1 Prophylactic and/or therapeutic agent for fatty liver |
| 03/20/2008 | WO2008032432A1 Gel type enteric nutrient |
| 03/20/2008 | WO2008031501A2 2-phenoxy nicotine acid derivative and use thereof |
| 03/20/2008 | WO2008031188A1 Vitamin d compositions and method of administration to a human being |
| 03/20/2008 | WO2008012470A3 Substituted imidazolone derivatives, preparation and uses |
| 03/20/2008 | WO2008005910A3 Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| 03/20/2008 | WO2007140174A3 Compounds and methods for modulating fxr |
| 03/20/2008 | WO2007136696A3 Use of substituted azetidinone compounds with cetp inhibitors for the treatment of sitosterolemia |
| 03/20/2008 | WO2007125385A3 Treatment of renal disorders, diabetic nephopathy and dyslipidemias |
| 03/20/2008 | WO2007115058A3 Thiadiazolidinone inhibitors of ptpase |
| 03/20/2008 | WO2007083119A3 Methods |
| 03/20/2008 | WO2007054303A3 Diaryl urea for treating diabetic neuropathy |
| 03/20/2008 | WO2001025398A3 Process for inducing functional tolerance to gene transfer products |
| 03/20/2008 | US20080071066 Heparin binding protein for use in controlling angiogenesis and as wound healing agent |
| 03/20/2008 | US20080071065 Fibroblast Growth Factor-Like Polypeptides |
| 03/20/2008 | US20080070990 Use of ractopamine enantiomers |
| 03/20/2008 | US20080070987 [{3-[(propionylamino)methyl]phenyl}methanammonium]6[V10O28]6-; semicarbazide-sensitive amine oxidase (SSAO)/Vascular Adhesion Protein-1 (VAP-1) agonist; antidiabetic, elevated plasma glucose levels, and ketoacidosis; "insulin mimetics", increase cells' sensitivity for glucose uptake |
| 03/20/2008 | US20080070983 2-O- (Beta-D-Glucopyranosyl) ascorbic acid, process for its production, and foods and cosmetics containing compositions comprising it |
| 03/20/2008 | US20080070964 Opioid receptor active compounds |
| 03/20/2008 | US20080070957 p-(2-alkoxy-2-acylethyl)biphenyl compounds; 1-[4'-(2-ethoxy-3-morpholin-4-yl-3-oxopropyl)biphenyl-3-yl]-3-heptyl-1-methylurea; human or veterinary medicine: dermatology, cardiovascular diseases, immune diseases,; lipid metabolism diseases; Peroxisome Proliferator-Activated Receptor modulator |
| 03/20/2008 | US20080070954 inhibitors of histone deacetylase; antiproliferative; anticancer; 8-[3-(4-methylbenzenesulfonyl)-ureido])-octanoic acid hydroxyamide |
| 03/20/2008 | US20080070949 Polymorphs of rimonabant |
| 03/20/2008 | US20080070947 Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis |
| 03/20/2008 | US20080070944 Novel methods using aminobenzoic acid compounds |
| 03/20/2008 | US20080070937 Small molecule inhibitors of kynurenine-3-monooxygenase |
| 03/20/2008 | US20080070935 Isoquinoline, Quinazoline and Phthalazine Derivatives |
| 03/20/2008 | US20080070928 Novel 2-Heteroaryl-Substituted Benzimidazole Derivative |
| 03/20/2008 | US20080070922 DDPIV inhibitor: selected from (S)-1-{2-[5-cyanopyridin-2yl)amino]ethyl-aminoacetyl)-2-cyano-pyrrolidine, vildagliptin, Sitagliptin, saxagliptin; PDGF receptor tyrosine kinase inhibitor: selected from imatinib, imatinib methanesulfonate; impaired glucose metabolism; impaired glucose tolerance |
| 03/20/2008 | US20080070921 Melanocortin receptor modulators; sexual disorders, obesity, cachexia, eating disorders; for example 1,4-bis(2-amino-3-p-tolyl-propionyl)-2-isobutyl-5-(4-(2-aminoethylamino)butyl)piperazine |
| 03/20/2008 | US20080070911 Ion channel modulating compounds and uses thereof |
| 03/20/2008 | US20080070905 An enzyme in the tryptophan degradation pathway, used to treat neurodegenerative disorders, certain cancers, drug addiction; 2-sulfonamido-substituted oxazole, imidazole or thiazole compounds such as 3,4-dimethoxy-N-[4-(3-nitrophenyl)-5-dimethylaminomethyl-1,3-thiazole-2-yl]benzenesulfonamide |
| 03/20/2008 | US20080070902 Cinnamide Compound |
| 03/20/2008 | US20080070896 Insulin secretagogue and hypoglycemic agent; pyrimidine derivatives condensed with a non-aromatic ring selected from dihydrothiophene, dihydrofuran, cycloalkane moiety; 1-[2-(4-chloro-2,5-difluorophenyl)-6,6-dioxido-5,7-dihydrothieno[3,4-d]pyrimidin-4-yl]-4-(3-hydroxypropyl)piperidin-4-ol for example |
| 03/20/2008 | US20080070892 2,7-diazaspiro[3.5]nonane; TRPV1 antagonists; Transient receptor potential V1 (TRPV1); T-type calcium channel blockers; Niemann-Pick C1-like (NPC1L1) antagonists; combination therapy with other antidiabetics, analgesics |
| 03/20/2008 | US20080070890 Spirocyclic Azetidinone Compounds and Methods of Use Thereof |
| 03/20/2008 | US20080070889 Spirocyclic azetidin(one); e.g. 2,7-diazaspiro[3.5]nonan-1-one; T-type calcium channel blockers; Niemann-Pick C1-like (NPC1L1) antagonists |
| 03/20/2008 | US20080070887 Diaryl Ether Derivatives and Uses Thereof |
| 03/20/2008 | US20080070869 Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators |
| 03/20/2008 | US20080070868 Novel Thiazole Inhibitors of Fructose 1,6-bisphosphatase |
| 03/20/2008 | US20080070867 2-Imidazolone and 2-Imidazolidinone Heterocyclic Inhibitors of Tyrosine Phosphatases |
| 03/20/2008 | US20080070864 Modulating the activity of farnesoid X receptor (FXR) and/or orphan nuclear receptors; N-[3-(2,4-dimethylphenyl)-4-oxo-3,4-dihydroquinazolin-2-ylmethyl]benzenesulfonamide |
| 03/20/2008 | US20080070843 Protein kinase inhibitors comprising atp mimetics conjugated to peptides or peptidomimetics |
| 03/20/2008 | US20080070826 Cholesterol-reducing diet |
| 03/20/2008 | US20080070301 Preparing xenograft of pig pancreatic tissue for use in prevention and treatment of diabetic disorders; antidiabetic agents |
| 03/20/2008 | US20080070259 Using presence or absence of mutation in metalloenzyme polynucleotides as diagnostic indicator of cardiovascular and neurodegenerative disorders |
| 03/20/2008 | US20080069910 Preventive, Relieving or Therapeutic Composition for Diabetes Mellitus and/or Diabetic Nephropathy |
| 03/20/2008 | US20080069890 Method for treating patients with implants of islets which have been kept in long term, in vitro culture |
| 03/20/2008 | US20080069869 Formulations and methods for modulating satiety |
| 03/20/2008 | US20080069851 Substituted n-aminomethylene sulfonamides, production and use thereof as medicaments |
| 03/20/2008 | US20080069799 Use of il-22 for the treatment of conditions of metabolic disorders |
| 03/20/2008 | US20080069798 Hyperlipidemia, obesity, hyperinsulinemia and diabetes; gene therapy |
| 03/20/2008 | US20080069797 Rapamycin and il-10 for the treatment of immune diseases |
| 03/20/2008 | CA2663504A1 Azetidine and azetidone derivatives useful in treating pain and disorders of lipid metabolism |
| 03/20/2008 | CA2663503A1 Azetidinone derivatives and methods of use thereof |
| 03/20/2008 | CA2663502A1 Azetidinone derivatives and methods of use thereof |
| 03/20/2008 | CA2663501A1 Treating pain, diabetes, and disorders of lipid metabolism |
| 03/20/2008 | CA2663500A1 Spiro-condensed azetidine derivatives useful in treating pain, diabetes and disorders of lipid metabolism |
| 03/20/2008 | CA2663434A1 Spirocyclic azetidinone derivatives for the treatment of disorders of lipid metabolism, pain, diabetes and other disorders |